Referenzstandards von Eurofins | PHAST

USP-1604632

Risedronate Related Compound B (20 mg) ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
R044J0
‭N/A‬
x
x
x